RecruitingNCT03657693
MRI in BPD Subjects
MRI for Quantitative Measurement of Pulmonary Growth and Development in Term and Extremely Pre-Term Babies in the BPD Center of Excellence
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
160 participants
Start Date
May 4, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators are wanting to learn more about early development of the lungs and to help them better understand prematurity and the development of a breathing disorder call BPD (Bronchopulmonary Dysplasia)
Eligibility
Max Age: 4 Months
Inclusion Criteria1
- any term age NICU patient
Exclusion Criteria5
- \- ECMO,
- Evidence of congenital diseases that may affect lung development, such as congenital diaphragmatic hernia,
- Suspected muscular dystrophy or neurologic disorder that may affect lung development.
- Significant genetic or chromosomal abnormalities that may affect lung development
- Evidence of any respiratory infection at the time of imaging (imaging may be rescheduled for a common viral infection such as a cold).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTNICU MRI
MRI device that is not FDA approved.
DIAGNOSTIC_TESTPolysomnography
Polysomnography to better determine obstruction index in the airway.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03657693
Related Trials
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT0427840451 locations
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
NCT069253601 location
Inhaled Ciclesonide Study in Preterm Infants
NCT065892451 location
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
NCT063732892 locations
Pressure-Sensing Mattresses and Mechanical Ventilation Weaning in Neonatal
NCT065791571 location